ELANCO ANIMAL HEALTH INC (ELAN) Stock Price, Quote, News and Overview
NYSE:ELAN - New York Stock Exchange, Inc. - US28414H1032 - Common Stock - Currency: USD
ELAN Quote, Performance and Key Statistics
12.67
+0.05 (+0.4%)
The current stock price of ELAN is 12.67 USD. In the past month the price increased by 33.93%. In the past year, price decreased by -24.54%.
ELAN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.98 | 678.00B | ||
| JNJ | JOHNSON & JOHNSON | 15.19 | 367.19B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.48 | 302.61B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.54 | 222.20B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.87B | ||
| MRK | MERCK & CO. INC. | 9.99 | 195.88B | ||
| PFE | PFIZER INC | 7.18 | 130.67B | ||
| SNY | SANOFI-ADR | 13.67 | 128.55B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.41 | 95.71B | ||
| GSK | GSK PLC-SPON ADR | 7.06 | 78.75B | ||
| ZTS | ZOETIS INC | 26.91 | 72.25B | ||
| HLN | HALEON PLC-ADR | 22.57 | 49.87B |
Related stock screener links
About ELAN
Company Profile
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,000 full-time employees. The company went IPO on 2018-09-20. The firm's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). The company has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The firm's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Company Info
ELANCO ANIMAL HEALTH INC
2500 Innovation Way N
Greenfield INDIANA 46140 US
CEO: Jeffrey N. Simmons
Employees: 9225
Phone: 18773526261
ELANCO ANIMAL HEALTH INC / ELAN FAQ
What is the stock price of ELANCO ANIMAL HEALTH INC today?
The current stock price of ELAN is 12.67 USD. The price increased by 0.4% in the last trading session.
What is the ticker symbol for ELANCO ANIMAL HEALTH INC stock?
The exchange symbol of ELANCO ANIMAL HEALTH INC is ELAN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ELAN stock listed?
ELAN stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ELANCO ANIMAL HEALTH INC stock?
20 analysts have analysed ELAN and the average price target is 14.23 USD. This implies a price increase of 12.3% is expected in the next year compared to the current price of 12.67. Check the ELANCO ANIMAL HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ELANCO ANIMAL HEALTH INC worth?
ELANCO ANIMAL HEALTH INC (ELAN) has a market capitalization of 6.29B USD. This makes ELAN a Mid Cap stock.
How many employees does ELANCO ANIMAL HEALTH INC have?
ELANCO ANIMAL HEALTH INC (ELAN) currently has 9225 employees.
What are the support and resistance levels for ELANCO ANIMAL HEALTH INC (ELAN) stock?
ELANCO ANIMAL HEALTH INC (ELAN) has a support level at 12.66 and a resistance level at 12.81. Check the full technical report for a detailed analysis of ELAN support and resistance levels.
Is ELANCO ANIMAL HEALTH INC (ELAN) expected to grow?
The Revenue of ELANCO ANIMAL HEALTH INC (ELAN) is expected to grow by 2.15% in the next year. Check the estimates tab for more information on the ELAN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ELANCO ANIMAL HEALTH INC (ELAN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ELAN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ELAN, evaluating the profitability, health, valuation and growth aspects
- ELANCO ANIMAL HEALTH INC (ELAN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ELANCO ANIMAL HEALTH INC (ELAN) Sales and EPS estimates to see what analysts future expectations are.
- ELANCO ANIMAL HEALTH INC (ELAN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ELANCO ANIMAL HEALTH INC (ELAN) Insider and Institutional Ownership to learn about the owners and their transactions.
- ELANCO ANIMAL HEALTH INC (ELAN) Stock Chart to make your own analysis
- ELANCO ANIMAL HEALTH INC (ELAN) Latest news and press-releases to stay up to date.
Does ELANCO ANIMAL HEALTH INC (ELAN) stock pay dividends?
ELAN does not pay a dividend.
When does ELANCO ANIMAL HEALTH INC (ELAN) report earnings?
ELANCO ANIMAL HEALTH INC (ELAN) will report earnings on 2025-08-06, before the market open.
What is the Price/Earnings (PE) ratio of ELANCO ANIMAL HEALTH INC (ELAN)?
The PE ratio for ELANCO ANIMAL HEALTH INC (ELAN) is 13.48. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 12.67 USD. Check the full fundamental report for a full analysis of the valuation metrics for ELAN.
What is the Short Interest ratio of ELANCO ANIMAL HEALTH INC (ELAN) stock?
The outstanding short interest for ELANCO ANIMAL HEALTH INC (ELAN) is 5.05% of its float. Check the ownership tab for more information on the ELAN short interest.
ELAN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to ELAN. When comparing the yearly performance of all stocks, ELAN is a bad performer in the overall market: 62.14% of all stocks are doing better.
ELAN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ELAN. ELAN has an average financial health and profitability rating.
ELAN Financial Highlights
Over the last trailing twelve months ELAN reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS increased by 20.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.43% | ||
| ROA | 2.88% | ||
| ROE | 5.87% | ||
| Debt/Equity | 0.68 |
ELAN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 77% to ELAN. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of -6.47% and a revenue growth 2.15% for ELAN